Company Filing History:
Years Active: 2001-2006
Title: Judy Ruckman: Innovator in Nucleic Acid Ligands
Introduction
Judy Ruckman is a prominent inventor based in Boulder, CO (US). She has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid ligands. With a total of 2 patents, her work has implications for both therapeutic and diagnostic applications.
Latest Patents
Ruckman's latest patents focus on the isolation of nucleic acid ligands to integrins using the SELEX process. SELEX, which stands for Systematic Evolution of Ligands by EXponential enrichment, is a powerful method for identifying specific nucleic acid sequences that bind to target proteins. The nucleic acid ligands developed through her research are valuable tools in the medical field, offering potential for innovative therapeutic and diagnostic agents.
Career Highlights
Judy Ruckman is currently associated with Gilead Sciences, Inc., where she continues to advance her research in biotechnology. Her work has garnered attention for its potential to revolutionize treatment options in various medical conditions.
Collaborations
Throughout her career, Ruckman has collaborated with notable professionals in her field, including Larry M Gold and Andrew Stephens. These collaborations have further enriched her research and contributed to the advancement of nucleic acid technologies.
Conclusion
Judy Ruckman stands out as an influential inventor in the biotechnology sector, with her innovative work on nucleic acid ligands paving the way for future advancements in therapeutic and diagnostic applications. Her contributions continue to impact the scientific community and improve healthcare solutions.